Blood cancer patients in their 40s and 50s are backing calls for Pharmac to overhaul its funding model and consider the wider costs of disease in funding decisions. Ellen O'Dwyer reports.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
